Psychiatrische Praxis, Table of Contents Psychiatr Prax 2006; 33(7): 356-357DOI: 10.1055/s-2006-954425 Fortbildung und DiskussionSzene© Georg Thieme Verlag KG Stuttgart · New YorkMessung der subjektiven Lebensqualität bei Patienten mit Schizophrenie aus Sicht der pharmazeutischen IndustrieRecommend Article Abstract Full Text References Literatur 01 Naber D . Karow A . Lambert M . Psychosocial outcomes in patients with schizophrenia: Quality of life and reintegration. Curr Opin Psychiatry. 2002; 15 31-36 02 Franz M . Lis S . Plüddemann K . Gallhofer B . Conventional versus atypical neuroleptics: Subjective quality of life in schizophrenic patients. Br J Psychiatry. 1997; 170 422-425 03 Kilian R . Dietrich S . Toumi M . Angermeyer MC . Quality of life in persons with schizophrenia in out-patient treatment with first- or second-generation antipsychotics. Acta Psychiatr Scand. 2004; 110(2) 108-118 04 Ritsner M . Gibel A . Perelroyzen G . Kurs R . Jabarin M . Ratner Y . Quality of life outcomes of risperidone, olanzapine, and typical antipsychotics among schizophrenia patients treated in routine clinical practice: a naturalistic comparative study. J Clin Psychopharmacol. 2004; 24(6) 582-591 05 Karow A . Czekalla J . Dittman RW . Siemer A . Wagner T . Lambert M . Schimmelmann BG . Naber D . Association of subjective well-being and compliance. J Clin Psychiatry 2006 (in press). 06 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Methoden 2005. www.iqwig.de .
